INDIA: HIV Prevalence and Predictors Among Rescued Sex- Trafficked Women and Girls in Mumbai, India

Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

INDIA: HIV Prevalence and Predictors Among Rescued Sex- Trafficked Women and Girls in Mumbai, India

Journal of Acquired Immune Deficiency Syndromes Vol. 43; No. 5: P. 588-593, (12.15.2006) - Friday, December 15, 2006
Jay G. Silverman, PhD; Michele R. Decker, MPH; Jhumka Gupta, MPH; Ayonija Maheshwari, MD, MPH; Vipul Patel; Anita Raj, PhD

Although India's HIV epidemic has spread rapidly among female sex workers, and large numbers of women and girls are trafficked for sex each year, few HIV studies of this population have been conducted. In the current study, the authors examined the prevalence and predictors of HIV infection in sex-trafficked women and girls rescued from Mumbai brothels.

A total of 175 cases of sex-trafficked women and girls were reviewed for HIV test results, prevalence, risk factors, and demographics.

Of the cases studied, 22.9 percent tested positive for HIV. The average age of trafficked workers with HIV was 15.9 years, compared to 17.2 years for uninfected workers (P=0.06). Minors reported longer periods of confinement than older trafficked women (18.5 months vs. 9.6 months; P=0.007). Female sex workers trafficked from the states of Karnataka and Maharashtra were more likely to be HIV-positive than those from West Bengal (odds ratio=7.35, 95 percent confidence interval: 2.23-24.21). A longer duration of brothel work was positively associated with HIV infection, with a 3-4 percent increased risk for HIV infection for each additional month of captivity.

These "findings demonstrate the need for increased attention to HIV among young victims of sex trafficking in research and practice and to the rescue of sex trafficking victims as a form of HIV prevention," researchers concluded.
061215
AD062437

Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.